KRYS EBITDA
Krystal Biotech Inc · EBITDA
KRYS EBITDA
Latest reported$220.00Mperiod ending
KRYS TTM EBITDA (-$4.77M → $220.00M)
TTM EBITDA
High-resolution chart · PNG
KRYS ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| 219,995,000 | |
| 200,668,000 | |
| 182,731,000 | |
| 193,290,000 | |
| 180,176,000 | |
| 154,945,000 | |
| 117,139,000 | |
| 79,138,000 | |
| 124,788,000 | |
| 69,969,000 | |
| 27,532,000 | |
| -15,595,000 | |
| -126,582,000 | |
| -121,982,000 | |
| -135,920,000 | |
| -125,979,000 | |
| -111,910,000 | |
| -100,475,000 | |
| -65,309,000 | |
| -54,217,000 | |
| -48,544,000 | |
| -39,208,000 | |
| -30,353,000 | |
| -26,327,000 | |
| -22,345,000 | |
| -21,699,000 | |
| -21,332,000 | |
| -19,726,000 | |
| -17,547,000 | |
| -14,281,000 | |
| -11,996,000 | |
| -9,206,000 | |
| -8,322,000 | |
| -6,585,000 | |
| -4,772,000 | |
| -3,883,000 | |
| -2,117,000 |